# ## ||||Page| |---|---|---|---| |Reference and Administrative||Details|2-4| |Trustees' Report|||4-18| |independent
Auditors'|Report||19-22| |Statement ofFinancial|Activities||24| |Balance Sheet|||25| |Statement ofCash Flows|||27| |Analysis of Net Debt|||26| |Notes to the Financial|Statements||28-43| |Charity number|1146162| |---|---| |Company|07941827| |number|| |Registered office|Northumberland
House| |and operational|303-306 High Holborn| |address|London WC1V 7JZ| |Trustees|President| ||Professor Gail Davey OBE (to 7October 2021)| ||Professor Janet Hemingway
CBE,FRS, DSc, PhD, BSc,NAS (Foreign Associate),| ||FMedSci FRCP (Hon), FRES (Hon), FAAM (from 7October 2021)| ||Vice-President| ||David Mabey CBE DM FRCP FMedSci (from 7 October 2021)| ||Dr Wendy
Harrison
Bvet Med MPH PhD MRCVS (to 7October 2021)| ||Honorary Treasurer| ||Mr Tim Hazell BA (Hons) CGMA| ||Trustees| ||Professor Olufemi O. Adewole
(from 7October 2021)| ||Dr Buddha Basnyat (from 7October 2021)| ||Karen Brady BScHone| ||Mr Simon Bush BA MSc| ||Dr Sharon Cox BScMSc PhD (to 7 October 2021)| ||Professor Gail Davey OBE| ||Mr Tim Hazell BA (Hone) CGMA| ||Professor Kara Hanson
BA MPhil ScD (to 7 October 2021)| ||Dr Wendy Harrison
BVet Med MPH PhD MRCVS (to 7 October 2021)| ||Professor Janet Hemingway
CBE,FRS, DSc, PhD, BSc,NAS (Foreign Associate),| ||FMedSci FRCP (Hon), FRES (Hon), FAAM| ||Dr Said Abdallah
Jongo (from 7 October 2021)| ||Professor Diana Lockwood
MD, FRCP| ||Professor David Mabey CBEDM FRCP FMedSci| ||Professor Malcolm
Molyneux OBE, FRCP (to 7 October 2021)| ||Dr Christopher
Parry BA(Hons) MB Bchir PhD FRCP FRCPath (to 7October 2021)| ||Ms Sarah Rafferty BA MSc| ||Professor Pramod Samantaray
(from 7 October 2021)| ||Professor George Varghese
(from 7October 2021)| ||Professor Jimmy Whitworth
MD FMedSci FRCP FFPH DTM&H| ||Professor Bridget Wills, DM, FRCPCH, DTM&H| ||Dr Quudus
Yusuff
from 7October 2021| |Chief Executive|Tamar Ghosh BScMSc MBA| |Bankers|National
Westminster
Bank pic| ||1 Cavendish
Square| ||London W1A 4NU| |Investment|Eden Investment
Management| |Managers|Beaufort House| ||Brunswick
Road| ||Gloucester
GL1 1JZ| |Solicitors|Bates Wells &Braithwaite
London LLP| ||10Queen Street Place| ||London EC4R 1BE| ## |Auditors|From 7October 2021| |---|---| ||Knox Cropper| ||155London Road| ||Hemel Hempstead| ||Herffordshire| ||HP3 9SQ| ||To 7 October 2021| ||Moore Kingston
Smith LLP| ||Devonshire
House| ||60Goswell Road| ||London EC1M 7AD| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## # ## |ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE|| |---|---|---|---|---|---|---|---|---| |||A Com|an|Limited
b|Guarantee|||| |Statement|of Financial Activities|||(incorporating||the income and expenditure||| |||||account)||||| |||Forthe year ended 31|||March 2022|||| |||||Unrestricted||Restricted|Total|Total| |||||funds||funds|funds|funds| |||||2022||2022|2022|2021| |||||||6|6|E| |||Notes||||||| |Income from:||||||||| |Donations
and grants
Charitable
activities||2
3||28,208
290,052||974,275
7,727|1,002,483
297,779|657,734
302,194| |Investments||4||62,573|||62,573|58,425| |Other income||||723|||723|4,384| |Total||||381,556||982,002|1,363,558|1,022,737| |Expenditure
on:||||||||| |Raising funds:
Investment
management
Charitable
activities||||597,583||990,871|1,588,454|7,063
1,239,488| |Total||||597,583||990,871|1,588,454|1,246,551| |Net (losses)/gains|on investments|13||(19,067)|||(19,067)|306,169| |Net (expenditure)/income||||(235,094)||(8,869)|(243,963)|82,355| |Transfers
between|funds|||360||(360)||| |Net movement
in|funds|||(234,734)||(9,229)|(243,963)|82,355| |Reconciliation
of|funds|||||||| |Total funds brought|forward|||1,853,916||103,847|1,957,763|1,875,408| |Total funds carried forward||17||1,619,182||94,618|1,713,800|1,957,763| ||ROYAL|ROYAL|SOCIETY OF TROPICAL|SOCIETY OF TROPICAL|SOCIETY OF TROPICAL|SOCIETY OF TROPICAL|MEDICINE AND HYGIENE|MEDICINE AND HYGIENE| |---|---|---|---|---|---|---|---|---| |||||A Com|an|Limited|by Guarantee|| ||||||Balance Sheet|||| |||||As at||31 March 2022||| ||||||||2022|2021| ||||||Notes|||| |Fixed assets||||||||| |Intangible
assets|||||11||70,474|84,002| |Tangible assets|||||12||14,481|7,462| |Investments|||||13||1,517,395|1,467,407| ||||||||1,602,350|1,558,871| |Current assets||||||||| |Debtors|||||14||89,360|191,595| |Cash deposits||||||175,112||169,847| |Cash at bank and|in|hand||||173,733||355,321| |||||||438,205||716,763| |Creditors: amounts||falling|due||15|~351,353||305,604| |within one year||||||||| |Net current assets|||||||126,952|411,159| |Total assets less|current||liabilities||||1,729,302|1,970,030| |Creditors: amounts||falling|due|after|16||(15,502)|(12,267)| |more than one year||||||||| |Net assets|||||||1,713,800|1,957,763| |Charity funds||||||||| |Restricted funds|||||17||94,618|103,847| |Unrestricted
funds|||||17||1,619,182|1,653,916| |Total funds|||||||1,713,800|1,957,763| |March 20|22|| |---|---|---| |At 1 April||At 31 March| |2021f|Cash flowsf|2022f| |35~,321|~181.588|173733| ## ||||||Notes|Notes||2022|2021| |---|---|---|---|---|---|---|---|---|---| ||||||||||8| |Cash inflow used in operating
activities|||||||||| |Net cash used in operating
activities|||||||~149.~18||~46 831| |Cash flows (used in)/provided
by|investing|||activities|||||| |Dividend
income||||||||62,573|58,425| |Purchase of investments||||||13||(69,055)|(50,998)| |Transfer from/(to) cash deposits||||||||(5,265)|270,153| |Acquisition
oftangible fixed assets
Acquisition
ofintangible
fixed assets||||||12
11|(10,253)
~76.679||(5,137)
~49.692| |Cash flows (used in)/provided
by investing|||activities||||~32.979||222 751| |Net (decrease)/increase
in cash and||cash||equivalents||||(181,588)|175,920| |Cash and cash equivalents
at beginning||of|year|||||355,321|179,401| |Cash and cash equivalents
at end|ofyear|||||||173.733|355321| |Cash and cash equivalents
at end
Cash at bank and
in hand|ofyear|||comprise:||||173733|355321| |(i) Reconciliation
ofnet expenditure||to net cash||||flow from|operating|activities:|| |||||||||2022
8|2021f| |Net expenditure
as per statement|of|financial|||activities|||(243,963)|82,355| |Adjustments
for:|||||||||| |Depreciation
charge||||||12||3,234|1,396| |Amortisation
charge||||||11||23,598|18,777| |Net loss/(gain)
on revaluation
ofinvestments
Dividend
income||||||13
13||19,067
(62,573)|(306,169)
(58,425)| |Decrease
in debtors||||||||102,235|161,109| |Increase
in creditors||||||||8,884|54,126| |Net cash used in operating
activities||||||||149,518|46,831| ## ## ## ## ## ## ## ## ## ||2022|2021| |---|---|---| |Fellows' services|26%|26ok| |Journals|22%|22%| |Meetings|26%|26%| |Grants/awards|26%|26%| ## ## ## ## ## ## ## ## ## ## ## # ## ## ## ## |||Unrestricted|Restricted|Total|Total| |---|---|---|---|---|---| |||funds|funds|funds|funds| |||2022|2022|2022|2021| |||E|E|E|E| |Donations
Grants|and legacies|5,786
22,422|974,275|5,786
996,697|1,993
655,741| |||28,208|974,275|1,002,483|657,734| |Total 2021||48,450|609,284|657,734|| ## |Income|from c|haritable
activities||||| |---|---|---|---|---|---|---| ||||Unrestricted|Restricted|Total|Total| ||||funds|funds|funds|funds| ||||2022|2022|2022|2021| ||||E||E|E| |Fellow's|Annual|Subscriptions|50,991|7,727|58,718|52,972| |Journals|and Publications||224,220||224,220|237,287| |Meetings|and Events||14,841||14,841|11,935| ||||290,052|7,727|297,779|302,194| |Total 2021|||288,191|14,003|302,194|| ## |Investment|income||||| |---|---|---|---|---|---| |||Unrestricted|Restricted|Total|Total| |||funds|funds|funds|funds| |||2022|2022|2022|2021| |||E|E|E|E| |Investment|income|62,573||62,573|58,425| |Total 2021||58,425||58,425|| ||In 2021, inv|estment
incom|e ofE58,425 w|as unrestricted.|||| |---|---|---|---|---|---|---|---| |5.|Investment|management|costs||||| |||||Unrestricted|Restricted|Total|Total| |||||funds|funds|funds|funds| |||||2022|2022|2022|2021| |||||E|E|E|E| ||Investment|management|fees||||7,063| ||Total 2021|||7,063||7,063|| ## ## ## |Direct costs||| |---|---|---| ||2022|2021| ||E|| |Membership|15,380|15,188| |Journals|39,809|14,737| |Meetings|9,492|12,036| ||64,681|41,961| ## |Support and Governance
costs|shown
below can be apportioned|between
direct activity|| |---|---|---|---| |||2022|2021| ||Apportionment|E|E| |Membership|26%|147,730|151,943| |Journals|22%|125,002|128,567| |Meetings|26%|147,730|151,943| |Grants, medals and awards|26%|147,730|151,943| |||568,192|584,396| ## ## |Support costs (continued)||| |---|---|---| ||2022|2021| |||E| |Staff training
and recruitment
Audit and accountancy
fees
Travel and subsistence|10,833
44,865
4,957|1,478
31,950
568| |Legal and professional
fees
Marketing costs
Printing
and stationery
costs
Irrecoverable
VAT|4,598
926
2,390
8,954|400
4,614
1,303
26,000| |Postage
Bank charges and interest
ITand telephone
costs
Volunteer costs|189
23,686
731|116
4,961
30,046
753| |Other expenses
Insurance|552
1,184|3,374
1,358| |Rent, rates, servicing
and maintenance
External
HR services|94,202
2,920|93,420
710| |Governance
costs|8,217|3,222| |CRM Project
Wages and salaries
National
insurance|4,476
286,139
26,756|3,959
307,793
30,138| |Pension cost|14,785|18,059| |Depreciation
and amortisation|26,832|20,174| ||568,192|584,396| ## |This is stated after char|g|ing:||| |---|---|---|---|---| ||||2022
6|2021f| |Depreciation
oftangible
Amortisation
of intangible||fixed assets
fixed assets|3,234
23,598|1,396
18,777| |Auditors'
remuneration|-|audit|8,568|10,980| |Auditors'
remuneration|-|other services|33,092|| |Foreign exchange rate|variance||(75)|977| |Operating
lease rentals|||71,000|57,656| ## ## |Staffcosts||| |---|---|---| |Staff costs were as follows:||| ||2022|2021| ||5|F| |Wages and salaries|295,314|307,793| |Social security costs|26,756|30,138| |Pension costs|14,785|18,059| ||336,855|355,990| |The avera
follows:|ge
numbe|r ofperson|s employed
by the Charitable
Company|during
the year w|as as| |---|---|---|---|---|---| |||||2022|2021| |||||No.|No.| |||||7.33|8.17| |Average headcount||expressed|as a full time equivalent:||| |||||2022|2021| |||||No.|No.| |||||7.0|7.5| |Employees|whose|emoluments|exceeded f60,000 per annum:||| |||||2022|2021| |||||No.|No.| |F70,000 -|f79,999||||1| |E80,000 -|E89,999||||| |Intangible
fixed assets|Website
and CRM| |---|---| ||systems| ||6| |Cost|| |At 1 April 2021
Additions|154,179
10,070| |At 31 March 2022|164,249| |Amortisation|| |At 1 April 2021
Charge for the year|70,177
23,598| |At 31 March 2022|93,775| |Net book value|| |At 31 March 2022|70,474| |At 31 March 2021|84,002| ## ## |Tangible fixed assets|||| |---|---|---|---| ||Equipment|Office|Total| ||and|refurbishment|| ||furniture|6|| ||6||| |Cost|||| |At 1 April 2021
Additions|34,372
10,253|39,662|74,034
10,253| |At 31 March 2022|44,625|39,662|84,287| |Depreciation
At 1 April 2021
Charge for the year|28,510
3,034|38,062
200|66,572
3,234| |At 31 March 2022|31,544|38,262|69,806| |Net book value|||| |At 31 March 2022|13,081|1,400|14,481| |At 31 March 2021|5,862|1,600|7,462| ## ## ## ## ## |14.|Debtors||||| |---|---|---|---|---|---| |||||2022|2021| |||||F|6| ||Trade debtors|||(3,946)|26,108| ||Other debtors|||8,169|8,169| ||Prepayments
VAT repayable|and accrued income||66,082
19,055|157,318| |||||89,360|191,595| |15.|Creditors: amounts||falling due within one year||| |||||2022f|2021
5| ||Trade creditors|||45,962|29,977| ||Other taxation|and social security||8,461|33,582| ||Other creditors|||1,811|| ||Accruals and|deferred|income|255,019|242,045| |||||311,253|305,604| |16.|Creditors: amounts||falling due after more than one year||| |||||2022
8|2021f| ||Accruals and|deferred|income|15,502|12,267| ## ## ||||||m
S
Q
c
m|CV
EV
I
m
g
T|W||Cl
Cl
Cl
ID
CV||ED
T
T
I
IO|EO
ED
CEI
CV|CV
CO
Ol
T
ED||T
(0|(9
ID
(EE||CO
Q
CV
Tt
Ol|(0
CO
I
CD
TC|||Q
IO
(D|I|ICI
ED
Ol|Cl
Cl
CO
T| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||c
Cl
E||||||I|IO
Q
Ol|IO
Cl
Ol||I|I|I|I|\|I|I|I|I||| ||||||NSc||||||||||||||||||||| ||||||N||W|||||||||||Cl|||||||| ||||||4I||||||||||I|I||Cl
(0|I||I|I|||| ||||||Dlc||||||||||||||||||||| ||||||ICI-||||||||||||||||||||| |UJ
LU
(9
ZpZ
C(|ID
Cl|I
Z
LU|CV
CV
Q
CEI||h
'Clc
Cla
LU||W||ClQ
Cl
ID||CO
IO
(0
CD
IO||||||Ol|I|N
Cl
CD|Ol
DC
CO
1|T
CO|CEI
ID
CO
IO
(D
Ol|(EI
CO
IO
Q|T
CO
Q
Ol
CD|| |UJZ c
0
m
LLI
Cl (g
TL e
0—
a .—
E
p c
Gl
LL O.
0 E
$o
00
(0
LU O
I- III
I-~
~L' c
p
O
LU
ZO
c:z
Z
LU
IL ~
ILI
P IU
I- X
(0 I-
LU IU
I- p
P LL
z|||||Cl
E0Qc
m
4(
Q
c
m
m
UI|cv
I'
a
N'
I
I
Q|W||Cl
Cl
Cl
Cl||Cl
EO
EO
CO
EII
cv
T|ID
~|ED
IO
EO
T
CO
CII
ID
Cll
Cl
Cl
I||T
CV|ED
CEI|CD
~C|CO
ED
IO
cv|I
Cl
Q
CO
CO
IO|Ol
DI
CO|I
T
CO|CEI
Cl
Q
CV
CO
Ol|CO
CO
IO
Cl
T|cv
Cl
Cl
cv
CO
Ol
CO
C9
Cl
1|| |0|||||||||||||||||||||||||| |||||||||||||||||||||||S|||| ||||||||||||||||||||||0c|EE
(0|||| |||||N0c
0
c
Cl
E
IC
CD||||D4(
Clc
Ol
N
Cl
CI
Dl
D
c|olc0(SE
UJ
L
LL'0
m
S
10
(0
s|EC
N L
m
C
S
IC LS
ecP
S||(02
ID
N
ID
IJ
C0
~(0
m
S
IJ.|N
10c
T
S0
IhSc
ID0I-|L
—LL
(0
ID
0
NEO
'0~ S
N o
S-
ec~
Q
(0 (0
'c J:
~~0 0
S
IL|||10c
IL
c
aZ
CDTD s
0 CLL
IJ" Lo
Cl
mc S
ulS
(0 0
(0
NcS
CI|||LL
ClSa
O.
CL
C
Cl
E L
mmc
c
(0
ID
UO||0(0a
N
m,)
0( ID
S 0
N
Cl
D t7
L C
LL LL||D4(o
N
4l
Dl
0I-|Cl
10c
(00I-| ||||||Ol
m
0
C
ID|N
I
m
gI
«|||o
Cl
CI||IIC
CO
CO
CO|IO
«0|Cl
CD
IO
Cl||T
NT|ED
N|OI
'«l
EII|CO
ID
IO
«0
N|ED
IO
CO
CO
IO|Ol
III
CO
T|IO||III
CO
IO
CI|I
CO
CI|ID
I
IO
OI| |---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---| ||||||||Ot||I|||OI
CI|Ol
ID||I|I||I|I|I|I|I|I||CO
ED
T| |||||||||||||EO
CI|IO
CI||||||||||||ED
CI| ||||||N||III||||||||||||||||||| ||||||m
«||||I||I|I|||||||||||||| ||||||DIC||||||||||||||||||||| ||||||ICI-||||||||||||||||||||| |UJ|||||||||||||||||||||||||| |IU6z02|ID|th N
I-z N
IO
Zz|||Cl
'0
C
m0.
X
LU||||CIo
CI
IO||OI
T
CD||N
IO||I|I|I|I|CI
CI||I|CI
I
OI
tO|I|CI
NT
EO
N|TIO
IO
ID
N| |LLIZ
m
O
m
IU0 (g
«L'
m
O-
Q. .—
LU O
I- IC
~C
Ol Z
CI
O
LU
20
2 2
—LU|||||Cl
E00C||||||CI
IO
Ol
CO|I||||||||||CO
NT
EO|CO
IO
EO|CON
CON
ID|I
NN
CI| |I-
m
NL
0 E
po
IU «L
O0
EEI||IL OI
IU
IC,'
X IJJ
I- y
0 LU
I- Z
EO I-
UJ OI
I-0
0 U.
2|||CD
NN
Cl
I'.
0 0,
C ~
m «
CO IO||||CI
CI
CI
IO||CI
CO
CO
C«
CI
CI
N|IO|N
I
T||«C
CO
«EO
N N||CD
'IC
Itl|CO
Cl
IO
«0
N|Cl
O
N
Cl
Cl|CD
EO
CO
T||||IO
Cl
N
CI|CO
CI
IO
CO| |0|||||||||||||||||||||||||| ||||||||||||||||||||||0C|IDEE
IO|||| |||||'0
OI|N
C||||||||||||||||LL
OlS|0I00.|||| |||||C
L00
N'0
C
«
T0
C
m
E
V
IO
EO|T
«0
C
IO
IO
Cl
IO
m0.
E
O|||'0
m
OlC
00
N
OI0
DI'0
L|CD
IDE
IU
D
QI
ID
IO
m
00|N
C
ID0
m c
I
N
NC0
mcm0||ID
ID
ID
ID
m
)
0
O.|m0
IO0
C
IC
0I-|'0C
—LL
m
NEo
N»0
m 'g
Ve E
0
ID
ID
«OO
IO
m|||C
ul
I
SID
0
IL' lm
N
m cC
S.D
«I
m
EEJ CL||LL
a
N
0
X
N
CE
0|D
c
C
m
0|CL0.
«C0.
LE
«I
0
m
I0
0
C
ID
O|N
0I
mC
IO
D
C
LL|ID'0
I
0
IO
D
L
LL|IO'0
C
'0
CI
N
m«
IO
0
I-|N
C
ID
0
I-| ## ## ## ## ## ## ## |Analysis|of n|e|t assets between funds|||| |---|---|---|---|---|---|---| |||||Unrestricted|Restricted|Total| |||||funds|funds|funds| |||||2022|2022|2022| |||||E|E|E| |Intangible|fixed||assets|70,474||70,474| |Tangible|fixed|assets||14,481||14,481| |Fixed asset investments||||1,517,395||1,517,395| |Current assets||||32,334|94,618|126,952| |Creditors|due|in more than one year||(15,502)||(15,502)| |||||1,619,182|94,618|1,713,800| |Comparative||note||||| |||||Unrestricted|Restricted|Total| |||||funds|funds|funds| |||||2021|2021|2021| |||||E|E|E| |Intangible|fixed||assets|84,002||84,002| |Tangible|fixed|assets||7,462||7,462| |Fixed asset investments||||1,467,407||1,467,407| |Current assets||||307,312|103,847|411,159| |Creditors|due|in more than one year||(12,267)||(12,267)| |||||1,853,916|103,847|1,957,763| ## ## ##